Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
about
PPARγ and the Innate Immune System Mediate the Resolution of InflammationProresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis.Lipid mediators in the resolution of inflammationProresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolventThe resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolutionIdentification of resolvin D2 receptor mediating resolution of infections and organ protectionElucidation of novel 13-series resolvins that increase with atorvastatin and clear infectionsDHA- and EPA-derived resolvins, protectins, and maresins in airway inflammationAspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.Synthesis and anti-inflammatory and pro-resolving activities of 22-OH-PD1, a monohydroxylated metabolite of protectin D1.Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic InflammationProtectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection.Potential Impact of Nutrition on Immune System Recovery from Heavy Exertion: A Metabolomics PerspectiveMetabolic phenotyping reveals a lipid mediator response to ionizing radiationPlasma metabolomics in human pulmonary tuberculosis disease: a pilot studyBioactive products formed in humans from fish oils.Maresin 1 Biosynthesis and Proresolving Anti-infective Functions with Human-Localized Aggressive Periodontitis Leukocytes.Resolvin D4 stereoassignment and its novel actions in host protection and bacterial clearance.Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1.Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodelingResolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipinsTargeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.A mosquito lipoxin/lipocalin complex mediates innate immune priming in Anopheles gambiaeThe Regulation of Proresolving Lipid Mediator Profiles in Baboon Pneumonia by Inhaled Carbon Monoxide.Creating the Future of Evidence-Based Nutrition Recommendations: Case Studies from Lipid Research.Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney DiseaseDHA but Not EPA Emulsions Preserve Neurological and Mitochondrial Function after Brain Hypoxia-Ischemia in Neonatal Mice.Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial)Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages.Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by LipoxinsResolvin D1 Reduces Emphysema and Chronic Inflammation.Synthesis of the 16S,17S-Epoxyprotectin Intermediate in the Biosynthesis of Protectins by Human MacrophagesShort-term consumption of n-3 PUFAs increases murine IL-5 levels, but IL-5 is not the mechanistic link between n-3 fatty acids and changes in B-cell populationsResolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzaePro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 PhagocytosisKidney and Liver Injuries After Major Burns in Rats Are Prevented by Resolvin D2.Distal vessel stiffening is an early and pivotal mechanobiological regulator of vascular remodeling and pulmonary hypertension
P2860
Q26771755-DB2CCD03-BB5D-4037-B8AF-D17F2F1AB6F4Q27334082-2DEA1B1A-318A-409E-BC09-A3F606862158Q28250668-272D6DB6-E8C2-44F6-A8FC-94C1C3AB6E46Q28258840-708D8B0C-CFA3-4F9F-B37E-4629F9889BF3Q28260186-C3F81946-4E7B-46EC-8EF2-BB1FA1EF508AQ28265395-E05F73F6-6D52-4148-AC53-E5AE68FFB369Q28265796-4E3C4F3D-5CD4-4694-92E7-B4BDC358759FQ28269550-8B609911-B667-4C18-A2ED-C025B4C7F600Q30828467-60C4E203-4E15-4B55-9727-C3EE1F530E25Q30854633-AE6F0E0E-1762-4FE9-AC65-CBD640386033Q31122092-B43525CA-1E52-4E37-9C12-B6AC9124E0B2Q33569384-98A94E44-7A07-44D1-ACEA-EF8747254B00Q33749584-EBE061E0-C7F3-42F5-AEAB-4DDF0AA435F2Q34141817-07D8ECA2-7912-4453-B0D8-E7CFE0B4E2CCQ34343488-FC270C8C-850E-4681-A1F1-E9CBB99283DDQ34485375-DD4C86B0-98B8-4380-8AA4-FFAB774E3837Q34505126-93573B2F-C5EB-4513-B1C2-4952E37CFA52Q34508024-10815DE1-EC99-49D2-B437-A1080E869AE8Q34519343-1F86AA7F-57AD-4E4C-A23D-72178EB2C45EQ34523903-C0F51C7D-7D77-4CB6-81B4-942F28E73F1FQ34536887-CF7D5117-FD89-4ABB-A783-36C7486F107AQ34587774-CD0770AC-55B6-4D99-9A95-60521D2EDD64Q35070934-90348282-FC02-477A-A4A2-AB98A130A46DQ35744344-822DA981-AF0C-4B4E-A785-547B465EEEFAQ35972868-E94D1B7A-D9D5-4CB9-A906-12C0C87B7AB0Q36049280-A3728571-670F-47D7-AB2A-2D290EF0C12AQ36079167-035368CE-A45C-4461-B1A5-82F86E0E090AQ36095550-21A35EFF-8E89-4BFD-91B8-10F009017ED0Q36101290-E7FA3D36-4C09-439C-80C6-83FFBD3ACAF4Q36141602-32396BC9-E4E5-4F47-8A12-A681587B183EQ36174560-D0349F42-29D4-4167-9FE8-89096E982BA3Q36330155-167A2761-4AD4-4FAA-A4C8-C5B30528AD75Q36440765-6B45AD75-F9BC-435C-8C53-E7F071CF019AQ36509194-97BEA492-DC8C-4046-BD9F-94B46C8ACAEDQ36565510-1C734A29-25BF-4CC7-8C9F-D0306C47EF3DQ36591336-01396A00-DE43-4B6C-AB29-9F9A5D86EC55Q36656030-5693BA8E-8206-47C5-96AC-D0FA5ECC7001Q36777563-024CC571-18DD-486F-8C25-DDEF4F10FC58Q36803237-E4EE8E8A-25BB-4E19-96C5-72B61708FF5AQ37032506-F391F686-D304-49A8-8680-22BBCCA2FCBD
P2860
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification and signature p ...... pid mediators in human tissue.
@ast
Identification and signature p ...... pid mediators in human tissue.
@en
type
label
Identification and signature p ...... pid mediators in human tissue.
@ast
Identification and signature p ...... pid mediators in human tissue.
@en
prefLabel
Identification and signature p ...... pid mediators in human tissue.
@ast
Identification and signature p ...... pid mediators in human tissue.
@en
P2093
P2860
P1476
Identification and signature p ...... pid mediators in human tissue.
@en
P2093
Charles N Serhan
Jesmond Dalli
Masakazu Shinohara
Nan Chiang
Romain A Colas
P2860
P304
P356
10.1152/AJPCELL.00024.2014
P577
2014-04-02T00:00:00Z